My Member
Message Center
trending topics
market reports
-
MEDICAL JAPAN 2025 OSAKA Returns to Showcase Global Innovations
2025-02-17
-
Visit MEDICAL JAPAN 2023 TOKYO and take full advantage of the business opportunities!
2023-09-01
-
US to distribute 400 million free N95 masks at CVS, Walgreens in COVID fight
2022-01-21
-
Ethiopia receives additional 2.2 mln doses of Chinese-donated COVID-19 vaccines
2022-01-21
-
Hong Kong researchers say they develop novel material able to kill COVID-19 virus
2022-01-14
-
10 million more Chinese doses on way for Kenya
2022-01-14
-
Sino-African ties on track for a brighter future
2022-01-07
-
Efforts urged to boost COVID-19 vaccine production capacity in poor countries
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
-
UAE approves Sinopharm's new protein-based COVID-19 vaccine
2022-01-07
China's CanSino to offer tens of millions of COVID-19 vaccines to COVAX
2021-04-01
A logo of China's vaccine specialist CanSino Biologics Inc is pictured on the company's headquarters in Tianjin, China August 17, 2020. [Photo/Agencies]
BEIJING - China's CanSino Biologics Inc has proposed providing "tens of million of doses" of its single-dose COVID-19 vaccine to global vaccine sharing scheme COVAX, Reuters quoted a senior executive of the company as saying.
Pierre Morgon, senior vice president at CanSino, told the media outlet in an interview that the firm made the proposal in December last year to supply vaccines between late 2021 and the end of 2022.
"We are happy to go beyond 2022 if there was still an expectation to do so," Morgon was quoted in the report on Thursday.
The offering to COVAX, which is backed by the World Health Organization, is the lowest price that CanSino uses in markets outside China, where richer countries are subject to prices about three times higher, the report added.
(China Daily)
